Bharat Parenterals Ltd is in the business of manufacturing and marketing of formulationsBusiness Overview: BPL is a Gujarat-based WHO GMP & an ISO 10002: 2014, 9001: 2015 certified pharmaceutical company. It manufactures over 800 products spread over 20+ different categories including General Products, β-Lactum/ Cephalosporin Products, Formulations in the form...
Voltamp Transformers Limited has announced its unaudited financial results for the quarter ended June 30, 2025. The company reported a total income from operations of 423.58 crore. Net profit after tax for the period was 79.55 crore, a slight increase from 79.44 crore in the same quarter last year. Earnings...
Bharat Parenterals' subsidiary, Innoxel Lifesciences, has received the Establishment Inspection Report (EIR) from the U.S. FDA for its Vadodara finished dosage manufacturing facility. This signifies successful clearance of the U.S. FDA inspection, enabling acceptance of the site for commercial operations for products under inspection. This milestone reinforces Innoxel’s commitment to...
Bharat Parenterals Limited has shared its Investor Presentation for the quarter ended June 30, 2025, offering insights into its financial performance and strategic direction. For Q1 FY26, consolidated revenue from operations increased by 25.4% to 116.00 Cr, with EBITDA surging by 206.9% to 13.78 Cr. The company projects 12-14% standalone...
Bharat Parenterals Limited has announced the proposed appointment of M/s. Shah Mehta & Bakshi as the new Statutory Auditors for the company and its material subsidiary. The appointment is for a five-year term, subject to shareholder approval at the upcoming 32nd Annual General Meeting. M/s. Shah Mehta & Bakshi, a...
The company has announced that its Board of Directors has re-appointed Mr. Mukeshbhai Patel as a Non-Executive Independent Director for a second consecutive term of five years. This decision, which followed a review by the Nomination & Remuneration Committee, is subject to approval by the company's members at the upcoming...
